Skip to content

A Comparison of LASIK Outcomes Using Two Femtosecond Lasers

A Prospective, Randomized, Fellow Eye Comparison of Fellow Eyes Undergoing LASIK With the Intralase IFS150 Versus the Visumax

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03063164
Enrollment
7
Registered
2017-02-24
Start date
2017-02-14
Completion date
2018-11-13
Last updated
2021-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Keywords

Femtosecond laser, Visumax, Intralase IFS150, LASIK

Brief summary

Comparing LASIK outcomes using two femtosecond lasers

Detailed description

Patients will have a comprehensive eye examination once they express an interest in the study. This includes a slit lamp examination of the front of the eye and a dilated fundoscopic examination of the back of the eye. If there is any pathology noted that would exclude the patient from the study, then the investigator will inform the patient and make an appropriate referral. Patients deemed appropriate for the study after a comprehensive examination including computerized videokeratography can be enrolled. Patients will undergo bilateral simultaneous eye surgery. Which eye is treated with the Intralase IFS 150 and which eye is treated with VisuMax will be randomized so there is a 50% chance for either eye to receive one treatment. Patients will be seen on the day of surgery, post op day one, one month, three months, six months and one year. Patients will receive topical antibiotics in each eye for one week following the procedure. Patients will receive pred forte 1% ophthalmic drops for one week after treatment. Patients will also receive vigamox ophthalmic drops for four days after treatment. All of this is within the usual and customary standard of care for the treatment of patients undergoing LASIK surgery.

Interventions

DEVICEIntralase IFS150

Intralase flap creation

DEVICEVisumax

Visumax flap creation

Sponsors

Edward E. Manche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Eye to eye comparison

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects age 21 and older with healthy eyes. Nearsightedness between -0.25 diopters and -11.00 diopters with or without astigmatism of up to 5.00 diopters.

Exclusion criteria

* Subjects under the age of 21 * Subjects over the age of 60 * Subjects with corneal ectatic disorders

Design outcomes

Primary

MeasureTime frameDescription
ETDRS Uncorrected Visual AcuityAt post-operative month 12Number of eyes with an uncorrected visual acuity of 20/20 at 12 months measured using ETDRS testing charts

Secondary

MeasureTime frameDescription
Cochet Bonnet Asthesiometry Measurement of Corneal SensationAt postoperative month twelveCochet Bonnet Asthesiometry is measured on a scale of 1-6. Scores of 5 and above are considered normal.
Best Spectacle Corrected Visual AcuityPostoperative month 12Number of eyes losing 2 or more lines of corrected distance visual acuity measured by ETDRS testing charts
Anterior Segment Ocular Coherence Tomography Measurement of Flap ThicknessAt postoperative month oneAnterior segment ocular coherence tomography
Questionnaire Measuring Patient Preference for Laser DeviceIntraoperative (Approximately 1 minute after completion of surgery)Participants were asked if they preferred having LASIK surgery with either the Visumax laser, the Intralase iFS laser or had no preference between the two lasers.
Patient Reported Outcomes With LASIKOne month, three months, six months and twelve monthsPROWL study questionnaire
AberrometryOne three, six and twelve monthsAberrometry images will be obtained on the iDesign aberrometer

Countries

United States

Participant flow

Participants by arm

ArmCount
All Participants
Participants received treatment with Intralase IFS in one eye and treatment with Visumax in their fellow eye.
7
All Participants
Participants received treatment with Intralase IFS in one eye and treatment with Visumax in their fellow eye.
14
Total21

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
7 Participants
Race/Ethnicity, Customized
Asian
5 Participants
Race/Ethnicity, Customized
Caucasian
2 Participants
Region of Enrollment
United States
7 Participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 70 / 7
other
Total, other adverse events
0 / 70 / 7
serious
Total, serious adverse events
0 / 70 / 7

Outcome results

Primary

ETDRS Uncorrected Visual Acuity

Number of eyes with an uncorrected visual acuity of 20/20 at 12 months measured using ETDRS testing charts

Time frame: At post-operative month 12

ArmMeasureValue (COUNT_OF_UNITS)
Intralase IFS EyeETDRS Uncorrected Visual Acuity5 Eyes
Visumax EyeETDRS Uncorrected Visual Acuity5 Eyes
Secondary

Aberrometry

Aberrometry images will be obtained on the iDesign aberrometer

Time frame: One three, six and twelve months

Population: The data were corrupted and could not be analyzed

Secondary

Anterior Segment Ocular Coherence Tomography Measurement of Flap Thickness

Anterior segment ocular coherence tomography

Time frame: At postoperative month one

Population: Data were corrupted and could not be analyzed

Secondary

Best Spectacle Corrected Visual Acuity

Number of eyes losing 2 or more lines of corrected distance visual acuity measured by ETDRS testing charts

Time frame: Postoperative month 12

ArmMeasureValue (COUNT_OF_UNITS)
Intralase IFS EyeBest Spectacle Corrected Visual Acuity0 Eyes
Visumax EyeBest Spectacle Corrected Visual Acuity0 Eyes
Secondary

Cochet Bonnet Asthesiometry Measurement of Corneal Sensation

Cochet Bonnet Asthesiometry is measured on a scale of 1-6. Scores of 5 and above are considered normal.

Time frame: At postoperative month twelve

ArmMeasureGroupValue (COUNT_OF_UNITS)
Intralase IFS EyeCochet Bonnet Asthesiometry Measurement of Corneal SensationScore of greater than or equal to 57 Eyes
Intralase IFS EyeCochet Bonnet Asthesiometry Measurement of Corneal SensationScore of less than 50 Eyes
Visumax EyeCochet Bonnet Asthesiometry Measurement of Corneal SensationScore of greater than or equal to 57 Eyes
Visumax EyeCochet Bonnet Asthesiometry Measurement of Corneal SensationScore of less than 50 Eyes
Secondary

Patient Reported Outcomes With LASIK

PROWL study questionnaire

Time frame: One month, three months, six months and twelve months

Population: Questionnaire data were corrupted and could not be analyzed.

Secondary

Questionnaire Measuring Patient Preference for Laser Device

Participants were asked if they preferred having LASIK surgery with either the Visumax laser, the Intralase iFS laser or had no preference between the two lasers.

Time frame: Intraoperative (Approximately 1 minute after completion of surgery)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intralase IFS EyeQuestionnaire Measuring Patient Preference for Laser DevicePreferred Visumax3 Participants
Intralase IFS EyeQuestionnaire Measuring Patient Preference for Laser DevicePreferred Intralase IFS2 Participants
Intralase IFS EyeQuestionnaire Measuring Patient Preference for Laser DeviceNo preference2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026